Anuja Java, MD (she/her)

Txp Neph @WUNephrology Dir. Kidney Txp @stlouisva co-chair KDWG @clingenresource. AE @KidneyMed. Rsrch #complement #genetics #TMA #AMD #Preeclampsia RT#endorse

[Anuja Java, MD (she/her) @anuja_java]

Was thrilled to receive this letter about one of my transplant pts who made a donation to the hospital in my name.

As physicians, the trust & well-being of our pts matters most!!

This beautiful gesture tells me I am doing it right. Feeling blessed & happy😊 @WUNephrology⁩

[American Society of Onconephrology @onconephsociety]

🩸Thrombotic Microangiopathy in Patients with Cancer 🩸

Cancer associated TMA can be complex, especially when complement activation is involved.

This session by @anuja_java will explore the role of complement regulation and inhibition in these patients.

@rc_oncneph @onconeph

[American Society of Onconephrology @onconephsociety]

Our next session?

🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ?

Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi

Register 🔗: https://t.co/aGTcge4zaS

@rc_oncneph @onconeph @SheronLatcha

[American Society of Onconephrology @onconephsociety]

🦀🫘👩🏻‍⚕️Kidney Transplant Onconephrology

How do we approach cancer treatment in KTRs?

Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs

Register 🔗 : https://t.co/aGTcge4zaS

@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

[Anuja Java, MD (she/her) @anuja_java]

@LVRiella @kdjhaveri @ASNKidney @mgh_transplant @MGBKidneys Congratulations Leo!!

[American Society of Onconephrology @onconephsociety]

✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies

Cancer therapies continue to evolve, and so do the kidney complications we see with them.

🎙️ : @ZiolkowskiSusan

@onconeph @SheronLatcha @MaulinPatelDO

Register : https://t.co/aGTcge4zaS

[American Society of Onconephrology @onconephsociety]

Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity

This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?

@onconeph @SheronLatcha @ShrutiGkidney

[NKF Nephrology Professionals @NKF_NephPros]

Explore Genetics in Kidney Care

The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories.

Watch on demand: https://t.co/VqvbNs3MYf

[American Society of Onconephrology @onconephsociety]

Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic

This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

[American Society of Onconephrology @onconephsociety]

Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver.

A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions.

Hope to see many of you there!
@onconeph @rc_oncneph @SheronLatcha

[aHUS Alliance Action @aHUSAllianceAct]

Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM) this Friday for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd

[aHUS Alliance Action @aHUSAllianceAct]

Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM ) TODAY for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd

[Anuja Java, MD (she/her) @anuja_java]

@aHUS24Sept We are in this together 😊🙏

[Anuja Java, MD (she/her) @anuja_java]

Today, on #aHUSAwarenessDay, we recognize the patients and families living with a rare and often unpredictable disease, and the community working alongside them!!
Every story adds to what we know. Every question still unanswered gives us a reason to keep going.

[aHUS Awareness Day @aHUS24Sept]

🔬 Diagnosing #aHUS remains a clinical challenge. Clinicians & researchers: Help others navigate complex aHUS diagnosis & care by sharing your work/insights with colleagues w/#aHUS24Sept. An expert review from @anuja_java on this complex #raredisease:
https://t.co/lk7lPAxTxC

[WashU Nephrology @WashUNephrology]

👏Check out recent publications @WashUNephrology by @Myasirbaloch, @anuja_java, @HumphreysLab, Chenjian Gu, and Yili Fang (Maggie Chen Lab).
https://t.co/JzW11wNEB8

[Fong Voon Ken @Ironken6]

ISN e-symposium today on genetic and clinical implications in aHUS management @anuja_java

@ISNkidneycare
@ISNeducation
#ThisIsISN
#ISNWebinar

[Anuja Java, MD (she/her) @anuja_java]

@JayaKala11 @SandeepSahayMD Jaya, that was a beautiful tribute to Sandeep. I didn’t get a chance to come see you. Had to fly out for another meeting.

[Anuja Java, MD (she/her) @anuja_java]

@DrBetofMDPhD @DanaFarber @ShrutiGkidney @mghmedres That was a fantastic talk!!!

[Matthew Sparks, MD @Nephro_Sparks]

We are hiring a nephrologist at the Durham VA in North Carolina. I have been practicing here for 19 years and would love to have you join us in a wondefrful academic environment. See the job description attached or reach out to me if you are interested

https://t.co/IVtSous08q

[Anuja Java, MD (she/her) @anuja_java]

Congrats @ShrutiGkidney & @rc_oncneph for an engaging symposium! There is still so much to understand about complement in cancer, which makes the road ahead all the more exciting. Thank you for having me! Fantastic talks by @aishaikh @HerrmannMd @PepaSolerR @onconeph

[OncoNeph Symposium 2026 Boston @OncnephBoston26]

🧵 Cancer & Complementology with Anuja Java

A fascinating look at how complement can be both friend and foe in cancer, and why context matters so much.

@anuja_java @rc_oncneph @ShrutiGkidney @harvardmed @DanaFarber